Hector F. DeLuca
Corporate Officer/Principal chez University of Wisconsin
Profil
Hector F.
DeLuca was the founder of Tetrionics, Inc. (founded in 1989) and Deltanoid Pharmaceuticals, Inc. (founded in 1999), where he held the title of Chairman, President & Chief Executive Officer.
Currently, he is a Professor at the University of Wisconsin.
Dr. DeLuca obtained a doctorate degree from the University of Wisconsin.
Postes actifs de Hector F. DeLuca
| Sociétés | Poste | Début |
|---|---|---|
| University of Wisconsin | Corporate Officer/Principal | - |
Anciens postes connus de Hector F. DeLuca
| Sociétés | Poste | Fin |
|---|---|---|
Tetrionics, Inc.
 Tetrionics, Inc. BiotechnologyHealth Technology Tetrionics, Inc. manufactures custom active pharmaceutical ingredients. Its services include synthesis and scale up, analytical chemistry, regulatory support, and current good manufacturing practice. The company was founded by Peter O. Johnson Sr., Herbert E. Paaren, and Hector F. DeLuca in 1989 and is headquartered in Madison, WI. | Fondateur | - |
Deltanoid Pharmaceuticals, Inc.
 Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Directeur Général | - |
Formation de Hector F. DeLuca
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Commercial Services |
Tetrionics, Inc.
Tetrionics, Inc. BiotechnologyHealth Technology Tetrionics, Inc. manufactures custom active pharmaceutical ingredients. Its services include synthesis and scale up, analytical chemistry, regulatory support, and current good manufacturing practice. The company was founded by Peter O. Johnson Sr., Herbert E. Paaren, and Hector F. DeLuca in 1989 and is headquartered in Madison, WI. | Health Technology |
